Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Remote Enhanced Assessment For Care At Home Reach Kit

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Remote Enhanced Assessment For Care At Home Reach Kit1
  • Healtheaccess1

Active Sponsors

  • University of Rochester1
  • United States Department of Commerce1
  • Robert Wood Johnson Foundation1
  • University of Pittsburgh1

Top Investigators

Related Conditions

  • Nonemergent Care1

Activity Timeline